Imperial College London
Portrait Picture

DrTristanLane

Faculty of Medicine, Department of Surgery & Cancer

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 3311 7317tristan.lane Website

 
 
//

Location

 

Remote or 4N12ANorth WingCharing Cross Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Bootun:2017:10.1002/bjs.10531,
author = {Bootun, R and Onida, S and Lane and davies},
doi = {10.1002/bjs.10531},
pages = {46--47},
publisher = {Wiley},
title = {Pilot study of the use of cyanoacrylate in the treatment of varicose veins},
url = {http://dx.doi.org/10.1002/bjs.10531},
year = {2017}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AB  - BackgroundThe treatment of varicose vein disease has changed significantly over the past decade. Endovenous ablation, especially using thermal methods, has become the new norm. However, it is often associated with patient discomfort during tumescent infiltration and the ablative procedure. The non-thermal, non-tumescent (NTNT) techniques are believed to be more advantageous as they eliminate these potential adverse events. In this study, the use of a new cyanoacrylate compound (Variclose vein sealing system, Biolas®, Ankara, Turkey) is assessed.MethodPatients with symptomatic varicose veins were invited to have their truncal saphenous incompetence treated using the new cyanoacrylate glue. Intraoperatively, their level of discomfort was assessed. Patients also had their clinical status and quality of life assessed at baseline and at 1 month post-operatively. ResultsSeventeen patients (20 limbs) were recruited. The mean age was 54 years. Eighty-five percent of limbs were reviewed at the 30-day follow-up. The mean baseline VCSS was 3.6 (±2.5), which improved to 2.4 (±3) at the 30-day point. Improvements were also noted in both the generic and specific quality of life scores. The median maximum pain score using a VAS was 34mm and 33mm for average pain. The complete/proximal occlusion rate at 30 days was 88%.ConclusionsThese preliminary results suggest that endovenous ablation using cyanoacrylate is safe and results in quality of life improvements similar to that seen in studies evaluating thermal techniques along with a low degree of intra-operative pain. Larger comparative studies are, however, required to confirm its effectiveness.
AU  - Bootun,R
AU  - Onida,S
AU  - Lane
AU  - davies
DO  - 10.1002/bjs.10531
EP  - 47
PB  - Wiley
PY  - 2017///
SN  - 1365-2168
SP  - 46
TI  - Pilot study of the use of cyanoacrylate in the treatment of varicose veins
UR  - http://dx.doi.org/10.1002/bjs.10531
UR  - http://hdl.handle.net/10044/1/48161
ER  -
Download